Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?
about
Multiple endocrine neoplasia type 2: achievements and current challengesMultiple endocrine neoplasia type 2 kindred with novel tandem RET mutations: Case report with an applied in silico mutational tolerance analysis.2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancerMiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.A complex endocrine conundrum.
P2860
Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Germline RET sequence variatio ...... orphism or causative mutation?
@ast
Germline RET sequence variatio ...... orphism or causative mutation?
@en
type
label
Germline RET sequence variatio ...... orphism or causative mutation?
@ast
Germline RET sequence variatio ...... orphism or causative mutation?
@en
prefLabel
Germline RET sequence variatio ...... orphism or causative mutation?
@ast
Germline RET sequence variatio ...... orphism or causative mutation?
@en
P2093
P2860
P1476
Germline RET sequence variatio ...... orphism or causative mutation?
@en
P2093
Alf Spitschak
Andreas Machens
Brigitte M Pützer
Kerstin Lorenz
P2860
P304
P356
10.1111/J.1365-2265.2011.04158.X
P577
2011-12-01T00:00:00Z